Tirofiban plus aspirin for moderate ischemic stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether adding a drug called tirofiban to aspirin can improve recovery outcomes in people who have had a moderate stroke. Tirofiban helps prevent new blood clots from forming, which may reduce the risk of further stroke and disability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Between 18 and 80 years old
- Had an acute ischemic stroke (a stroke caused by a blocked blood vessel) within the last 24 hours
- Have a moderate level of stroke symptoms (rated 4–10 on a standard stroke scale), including some weakness in an arm or leg
- Were independent before the stroke (could carry out daily activities without help)
- Not eligible if you have bleeding in the brain, a source of blood clots from the heart (like certain arrhythmias), or if you've already had clot-busting treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called tirofiban can help prevent stroke symptoms from getting worse after receiving a clot-busting drug. It is for patients with a narrowed brain artery and ongoing moderate to severe symptoms.
This trial tests the drug tirofiban (a blood thinner) to prevent another stroke in people who have had a mild stroke or high-risk TIA and have a narrowed artery in the brain. It must be started within 24 hours of symptoms.
This trial tests whether a combination of a clot-preventing drug (tirofiban) followed by two antiplatelet drugs (aspirin and clopidogrel) can improve recovery in people who have had a mild stroke. It aims to find a better way to prevent further strokes or worsening symptoms.
This trial tests whether adding a second medicine (tirofiban) to standard clot-busting treatment can help people who are not improving after the first hour. It is for people with a moderate to severe stroke who are not candidates for a clot-removal procedure.
This trial tests if adding a blood thinner called tirofiban after successful clot removal can improve recovery in people with severe stroke. It is for patients who had a large blockage and are treated within 24 hours of symptoms starting.
This trial tests adding the anti-clotting drug tirofiban to standard clot removal for people who have a stroke due to a narrowed artery in the brain. The goal is to see if this combination improves outcomes without raising bleeding risk.
Hear when a new Ischemic Stroke, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.